In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Celsion Corp (NASDAQ:CLSN) reported that Intracoastal Capital, Llc. has picked up 104,465 of common stock as of 2017-06-29.
The acquisition brings the aggregate amount owned by Intracoastal Capital, Llc. to a total of 104,465 representing a 1.9% stake in the company.
For those not familiar with the company, Celsion Corporation is an oncology drug development company. The Company’s product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall breast cancer (the DIGNITY Study). Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers. It has over three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, including Lysolipid Thermally Sensitive Liposomes, a heat sensitive liposomal based dosage form that targets disease with known therapeutics in the presence of mild heat; TheraPlas, a nucleic acid-based treatment for local transfection of therapeutic plasmids, and TheraSilence, a systemic dosage form for lung directed anti-cancer ribonucleic acid (RNA).
A glance at Celsion Corp (NASDAQ:CLSN) key stats reveals a current market capitalization of $8.34 Million based on $4.07 Million shares outstanding and a price at last close of $2.05 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-02-21, Martinez picked up 35,000 at a purchase price of $0.23. This brings their total holding to 180,081 as of the date of the filing.
On the sell side, the most recent transaction saw Egwu, unload 5,556 shares at a sale price of $2.08. This brings their total holding to 2,421,867.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an Celsion Corp (NASDAQ:CLSN) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.